A question lobbed during the news conference after the Vikings' playoff loss to the Rams could have been ignored, but it ...
BTIG sees positive readthroughs to Viking Therapeutics (VKTX) after Novo Nordisk (NVO) reported 22.7% weight loss with weekly CagriSema from the 68-week Phase 3 REDEFINE 1 trial in overweight ...